返回
Scisparc Ltd（SPRC）價格
SPRC 股價走勢圖
SPRC 收益
Scisparc Ltd
$1.07
1.9%
$0.02
收盤價：Jan 16, 16:00:00 GMT-5
$1.04
-2.8%
$-0.03
盤後：Jan 16, 20:00:00 GMT-5
關鍵數據
前收市價
$1.05
開盤價
$1.02
當日範圍
$1.01 - $1.16
52週區間
$0.9732 - $15.96
交易量
357.4K
平均成交量
4.4M
每股盈餘 (TTM)
-1.51
股息收益率
--
市值
$3.4M
什麼是 SPRC？
SciSparc Ltd. is a clinical stage pharmaceutical company, which focuses on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The firm is engaged in drug development programs based on repurposing a cannabinoid (Dronabinol): THX-110 for the treatment of Tourette syndrome (TS), for the treatment of Obstructive Sleep Apnea (OSA), and the treatment of Pain; THX-130 for the treatment of Mild Cognitive Impairment (MCI) and Traumatic Brain Injury (TBI); THX-150 for the treatment of infectious diseases; and THX-160 for the treatment of pain.